Clinical, Morphological and Multiplex Analysis of a Case of COVID-19-Associated Placental and Fetal Organ Damage at 16 Weeks Gestation

Abstract. COVID-19-associated damage to the placenta and fetal organs is possible among infected pregnant women. This phenomenon is associated with the presence of the virus in the placental tissue itself and transplacental transmission of SARS-CoV-2 from mother to fetus and occurs in case of severe course of the disease in the mother. However, reliable and clinically significant morphological changes in COVID-19-associated placental damage are still a subject of controversy and speculation. The aim of this article is to present a clinical case analysis and evaluation of the morphological features and results of multiplex analysis of COVID-19- associated fetal and placental tissue damage. Materials and methods. Placental and fetal tissue samples were examined using routine histological methods and immunohistochemical studies of the expression of antibodies to CD15 (MMA), CD3 (MRQ-39), CD68 (KP-1), CD138 (DB-A38). The spectroscopic study was performed using the InSpectr M spectrometer with an excitation wavelength of 532 nm. Results The study revealed an inflammatory infiltrate in the fetal membranes, in the umbilical vein wall, in the stroma of the villi, basal plate and intervillous space, forming thrombi of the vessels of the villi, chorionic plate, intervillous space, trophoblast necrosis, abundant deposition of perivillous fibrin. Spectroscopically, signs of changes in the quantitative and qualitative composition of the amino acids proline, phenylalanine, tyrosine and tryptophan, as well as the appearance of non-standard amino acids (hydroxyproline) and protein isoforms, signs of instability of the acid-base balance were revealed. Conclusion. Among the identified changes, both those characteristic of COVID-19-associated placental damage and non-specific ones associated with the body's inflammatory/cytokine response to COVID-19 and persistent placental infection are determined. The results of the multiplex analysis identified a promising direction in understanding the biological basis and essence of this pathology.

1. World Health Organization. WHO Coronavirus (COVID-19) [Internet]. World Health Organization. 2023. Available from: https://covid19.who.int/

2. World Health Organization. Maternal Mortality [Internet]. World Health Organization. World Health Organization: WHO; 2024. Available from: https://www.who.int/news-room/factsheets/detail/maternal-mortality

3. Glynn S.M., Yang Y.J., Thomas C., Friedlander R.L., Cagino K.A., Matthews K.C., et al. SARS-CoV-2 and Placental Pathology. American Journal of Surgical Pathology. 2021 Jul 26;46(1):51–7. doi: 10.1097/PAS.0000000000001772

4. Hecht J.L., Quade B., Deshpande V., MinoKenudson M., Ting D.T., Desai N., et al. SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers. Modern Pathology. 2020 Nov 1;33(11):2092–103. doi: 10.1038/s41379-020-0639-4

5. Schwartz D.A., Baldewijns M., Benachi A., Bugatti M., Bulfamante G., Cheng K., et al. Hofbauer Cells and COVID-19 in Pregnancy. Archives of Pathology & Laboratory Medicine. 2021 Nov 1;145(11):1328– 40. doi: 10.5858/arpa.2021-0296-SA

6. Watkins J.C., Torous V.F., Roberts D.J. Defining Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Placentitis. Archives of Pathology & Laboratory Medicine. 2021 Aug 2;145(11):1341–9. doi: 10.5858/arpa.2021-0246-SA